Literature DB >> 2005477

Caring for women at risk of HIV infection.

K Anastos1, S M Palleja.   

Abstract

HIV infection and AIDS are having a major and growing impact on women's lives. In addition to the usually described risk behaviors, many other medical or behavioral factors should prompt physicians to offer HIV counseling and testing. These include unusual or difficult-to-treat gynecologic conditions, unexplained vague systemic symptoms, and most sexually transmitted diseases. Use of alcohol and crack cocaine can be associated with a higher risk of HIV infection because of decreased risk reduction behaviors. The authors discuss the barriers to risk reduction among women deriving from their unequal social roles in relation to men and provide specific and detailed guidelines for counseling and educating women about HIV infection.

Entities:  

Mesh:

Year:  1991        PMID: 2005477     DOI: 10.1007/bf02599257

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  18 in total

Review 1.  Drug addiction and pregnancy: policy crossroads.

Authors:  W Chavkin
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

2.  Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-12-06       Impact factor: 17.586

3.  Sex tied to drugs = STD spread.

Authors:  M F Goldsmith
Journal:  JAMA       Date:  1988-10-14       Impact factor: 56.272

4.  Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus.

Authors:  A R Feingold; S H Vermund; R D Burk; K F Kelley; L K Schrager; K Schreiber; G Munk; G H Friedland; R S Klein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus.

Authors:  L K Schrager; G H Friedland; D Maude; K Schreiber; A Adachi; D J Pizzuti; L G Koss; R S Klein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

6.  Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group.

Authors:  M E St Louis; K J Rauch; L R Petersen; J E Anderson; C A Schable; T J Dondero
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

7.  Women--the missing persons in the AIDS epidemic.

Authors:  K Anastos; C Marte
Journal:  Health PAC Bull       Date:  1989

8.  Chronic vaginal candidiasis in women with human immunodeficiency virus infection.

Authors:  J L Rhoads; D C Wright; R R Redfield; D S Burke
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

9.  Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.

Authors: 
Journal:  MMWR Suppl       Date:  1989-06-16

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  3 in total

1.  HIV infection in women: diverse approaches to a growing problem.

Authors:  J M Agosti
Journal:  J Gen Intern Med       Date:  1991 Jul-Aug       Impact factor: 5.128

Review 2.  Clinical aspects of HIV infection in women.

Authors:  G O Coodley; M K Coodley; A F Thompson
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

3.  Women's self-disclosure of HIV infection: rates, reasons, and reactions.

Authors:  J M Simoni; H R Mason; G Marks; M S Ruiz; D Reed; J L Richardson
Journal:  J Consult Clin Psychol       Date:  1995-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.